Homeopathy and Chemotherapy by O. Leeser
Homeopathy and Chemotherapy by O. Leeser
Homeopathy and Chemotherapy by O. Leeser
AND
CHEMOTHERAPY
By
Ott~Uf1ft~(i
0\ C
~QmputQrised
.
!).O
NLVS/IVRI
Made aDd PriDted iD Great Britain by MaxweU, Love &; Co. Ltd.
Bradley'. BWldq., White l.i0ll Sveet, London, N.r
-
FOREWORD
THESE lectures were given, in the summer of 1943,
in response to a request from a number of German
refugeE" doctors in this c~ntry.
Hence the standard of knowledge assumed is
that of a non-homoeopathic general practitioner.
The publication has as its. sole aim to get diverg-
ing schools of medical thought and method better
acqua;<inted with each other. With this end in
view, a topical problem of contemporary Medicine
is examined.
O.L.
AN 'INTRODUCTION TO HOMOEOPATHY
IN this introduction no attempt will be made to
give anything beyond a rough sketch of the
method known as Homoeopathy. Indeed, once
you have realised that we hav.e to deal with a wide
field of applied scientific knowledge-a subject still
omitted from the ordinary medical curriculum-
you will not expect more than a bare outline.
I would suggest that as practitioners you can
best approach homoeopathy by regardillg it as a
method, indeed, the method, of individualising the
application of medicines to the sick person. In
homoeopathy it is not merely a question of con-
sidering the patient as an individual, a particular
disordered living entity, but the medicinal sub-
stance too is taken as an individual entity and
selected according to its particular merits or effects
on human beings as observed by previous tests or
experience. The trend of academic medicine is to
generalise, to diagnose and to treat illnesses and
their causes as far as these are accessible to
diagnosis and treatment. The trend of homoeo-
pathy is to individualise, to view and to treat each
patient as a person suffering under and from
particular conditions.
It may be safe to argue that both these
approaches to our problem of re-establishing the
patient in good health have their merits. On the
other hand, it is obviously unwise to neglect one
6 HOMOEOPATHY AND CHEMOTHERAPY
MALARIA.- QUININE
CH CH
folCOOCH
He eH
CM
HlI.C@HCH'CH=CHZ
I
~ ~
2
c
CH N H 0 . HC . HC C lola C 101.2
QUINOLINE N
Cg ..,'~ N "SECOND HALF"
CH
HCO coN~CH
He CI-{
~ C ~__ CM<JH
CH C
ISOMERIDES, C19 Hz, ON.
i. ROTATORY: CINCHONIDINE
d.. ROTATORY: CINCHONINE
eM N CH
ARSPHENAMINE MAPHARSEN
SYPHILIS-ARSEN., MERe., BIS" IODIDE 53
tion, was shown to fulfil the requirements for
direct parasiticidal action. It is assumed, therefore,
that this oxidation and splitting of arsphenamine
takes place in corpore. Mapharsen has been
administered also directly; being approximately
ten times more toxic than arsphenamine, it is
given in a tenth of the usual arsphenamine dose.
It is too early to say whether it has any advantage
apart from being easier to administer. Assuming
that the simpler compound is the active agent,
it has been suggested that it acts via the essential
sulphydril-compounds of the cells like glutathione
(cysteine-form). For once it is known that similar
phenyl-arsinoxides form dissociable compounds
with glutathione which annul their trypanocidal
action in vitro and in vivo. In vitro addition of
small quantities of glutathione (cysteine-form)
protects the parasites from being killed by
otherwise deadly concentrations of mapharsen. In
infected animals previous introduction of such
sulphydril compounds either considerably delays
or prevents destruction of the parasites by
arsinoxides. Lastly, also the toxic effects of large
arsphenamine doses in the non-infected animal
can be delayed or prevented by reduced gluta-
thione. That explains the old observations that
otherwise sufficiently high concentrations of
organic arsenic alia do not kill the parasites in
vitro if serum or tissue mash is added. Apparently
the sulphydril compounds of the organic matter
compete with those of the parasite cell. How much
more must this competition occur in the living
body where all the cells possess these SH-com-
pounds necessary for their respiration? If,
54 HOMOEOPATHY AND CHEMOTHERAPY
HCONHI!CM
Me CM
HcOr "eM
CH so far as they enhance
activity in special
bacterial infections.
They have one H of
~C __. "'lot / ' " III the S02NH2-grOUP re-
so. placed by various
~Mo SULPMAPVRIDI NE' rings, e.g., by the
HCOr
N
C ~c observation that in-
~OfH 1'1 Hz
troduction of the
essential SO.NH II
He ~H He CH -group into the diazo-
~c ~c dyes was seen to give
So,.-NHz N Hz a firmer fixation of the
PRONTOSIL colour to the proteins
of wool and silk. The
idea was to fixate organic compounds by means of
the same group on to bacteria. It remains to be
seen whether a similar" fixating" property plays
any part in the anti-bacterial action. Almost
certainly it is not solely responsible for it. Im-
I
. .NOC.coo~
HC-CH
C~ CH
has attracted
particular attention. This metabolite became
known to be essential to the mobility and growth
of the cocci (it seems to have certain vitamin-like
functions in mammals, too). Further it has been
noticed that the presence of this simple aromatic
amino-acid in the medium hampers the anti-
bacterial action of sulphanilamides. This
antagonism is interpreted as one between com-
petitors for the same groups or receptors.
Sulphanilamides would block up the bacterIUm
receptors for p-amino-benzoic acid and that would
account for the inhibitQry sequels to the bacteria.
Such competitive antagonism appears the more
probable from the similar chemical constitution
of the two compounds, both being p-amino-
benzene derivates. That would explain why the
para-position of the amino group is so essential
for the sulphanilamide action. If that group
is acetylated, the compound acetyl-sulphanil-
COCCAL INFECTIONS-SULPHANlLAMIDES 75
He
O
~c
eM
Clot
NH .OOC'CH,
vivo in varying proportions
so that the curative and the
noxious doses are subjected
to considerable fluctuations.
The antagonism ofp-amino-
benzoic acid to sulphanil-
amides is by no means the only one which
can be demonstrated in vitro and may also
CHs,S'CHa
CHII'SH
I dRs
CR'NHl! I
CRNBII
dOOR
CYSTEINE dOOR
METIDONlNE